SCHEMBL4698597

SCHEMBL4698597

O=C1C(Cc2ccc3cc(-c4cccc(Cl)c4Cl)ccc3c2)CCN1C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.53
ALDH1A1 P00352 2/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
CNR2 P34972 3/20 0.34
CNR1 P21554 2/20 0.34
PTPN11 Q06124 1/20 0.33
CHRNA7 P36544 1/20 0.33
ABL1 P00519 1/20 0.33
CYP2C9 P11712 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
ROCK2 O75116 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4697484 0.89 HSD11B1 (0.56) HSD11B1ALDH1A1MCOLN3CNR1ROCK2
SCHEMBL4698725 0.81 HSD11B1 (0.57) HSD11B1ALDH1A1MCOLN3
SCHEMBL4696657 0.81 HSD11B1 (0.56) HSD11B1ALDH1A1MCOLN3CNR1ROCK2
SCHEMBL4510178 0.81 HSD11B1 (0.71) HSD11B1ALDH1A1MCOLN3
SCHEMBL4751912 0.77 HSD11B1 (0.56) HSD11B1ALDH1A1
SCHEMBL4697530 0.77 HSD11B1 (0.61) HSD11B1ALDH1A1MCOLN3
SCHEMBL4697246 0.77 HSD11B1 (0.61) HSD11B1ALDH1A1MCOLN3NPC1RAB9A
SCHEMBL14143454 0.77 HSD11B1 (0.61) HSD11B1ALDH1A1MCOLN3
SCHEMBL3551503 0.76 HSD11B1 (0.71) HSD11B1ALDH1A1MCOLN3CYP2C9RAB9A
SCHEMBL4698838 0.76 HSD11B1 (0.60) HSD11B1ALDH1A1MCOLN3CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-09-04 US claimed
EP-1830841-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2008-07-02 EP claimed
EP-1830841-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-09-12 EP claimed
WO-2006068992-A1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2006-06-29 WO claimed
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-09-04 US disclosed
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 ELI LILLY AND COMPANY 2008-09-04 US disclosed
EP-1830841-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2008-07-02 EP disclosed
EP-1830841-B1 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214621-A1 Cycloalkyl Lactam Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 HSD11B1, HSD17B1, HSD3B1 HSD11B1 1/4885ALDH1A1 119/4885MCOLN3 2650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.